Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli

There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism (PE) at the University of Rochester Pulmonary Hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lachant, Daniel J., Bach, Christina, Fe, Alexander, White, R. James, Lachant, Neil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861033/
https://www.ncbi.nlm.nih.gov/pubmed/33569503
http://dx.doi.org/10.1183/23120541.00554-2020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861033/
https://www.ncbi.nlm.nih.gov/pubmed/33569503
http://dx.doi.org/10.1183/23120541.00554-2020

Ejemplares similares